This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-growth: Archive
Is Tapestry (TPR) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Tapestry (TPR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
TPRNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is ExlService Holdings (EXLS) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
ExlService Holdings (EXLS) could produce exceptional returns because of its solid growth attributes.
EXLSNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Fomento Economico (FMX) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Fomento Economico (FMX) possesses solid growth attributes, which could help it handily outperform the market.
FMXPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Everpure (P)
by Zacks Equity Research
Everpure (P) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
WisdomTree, Inc. (WT) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
WisdomTree, Inc. (WT) could produce exceptional returns because of its solid growth attributes.
WTPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is YPF Sociedad Anonima (YPF) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
YPF Sociedad Anonima (YPF) possesses solid growth attributes, which could help it handily outperform the market.
YPFNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Humacyte, Inc. (HUMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HUMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Sunrun (RUN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sunrun (RUN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RUNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in DraftKings (DKNG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for DraftKings (DKNG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DKNGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Diebold Nixdorf, Incorporated (DBD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Diebold Nixdorf, Incorporated (DBD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DBDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth